Skip to main content
Signal8

BlackRock Health Sciences Term Trust (BMEZ)

BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.

Industry: Asset Management

BlackRock Health Sciences Term Trust logo

BlackRock Health Sciences Term Trust

NYSE:BMEZFinancial Services
-0.12%$16.76
AH Close$16.76+0.00%vs close
Mkt Cap$1.05B
Float62.5M
O/S62.5M
Inst Own26.7%
Div Yield7.88%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$24.07M
Net Income$23.45M
Total Assets$774.59M
Free Cash Flow$65.52M
Debt & Equity
Debt 0%
Equity 100%
Total Debt$278K
Total Equity$768.57M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in BMEZ's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$774.59M
Liabilities$6.03M
Accounts Receivable$1.2M
Accounts Payable$0
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue$24.07M$8.19M-$25.97M$59.66M$5.24M$0
YoY Growth193.8%-131.5%-143.5%1038.2%--
Cost of Revenue$0-$8.46M$0$0$0$0
Gross Profit$24.07M$28.87M-$25.97M$6.4M$5.24M$0
Gross Margin100.0%352.4%100.0%10.7%100.0%-
Research and Development$0$0$0$0$0$0
Selling, General, and Administrative$356K$299K$362K$6.35M$5.17M$0
Other$262K$95K-$26.33M$0$0$0
Total Operating Expenses$617K$394K-$25.97M$6.35M$5.17M$0
Operating Income (EBIT)$927K$8.46M$1.54M$54K$69K$0
Operating Margin3.9%103.3%-5.9%0.1%1.3%-
Interest Expense$78$55$0$0$0$0
Interest Income$0$0$0$0$0$0
Other Income (Expense)$22.53M$11.55M-$28.01M$0$79.56M$0
Income Before Tax (EBT)$23.45M$20.02M-$26.47M$59.12M$79.56M$0
Income Tax Expense$0$0$0$0$0$0
Net Income$23.45M$20.02M-$26.47M$59.12M$79.56M$0
Net Income Margin97.4%244.3%101.9%99.1%1517.9%-
Supplementary Data
EPS1.771.44-2.100.5211.631.45
Diluted EPS1.771.44-2.100.5211.631.45
Weighted Average OS13.26M13.94M12.61M112.88M112.70M112.70M
EBITDA$927K$20.02M-$26.47M$54K$0$0
EBITDA Margin3.9%244.4%101.9%0.1%--
Balance Sheet
PeriodFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Assets
Current Assets
Cash and Cash Equivalents$71K$534$3K$960$212K$501K
Short-Term Investments$26.49M$0$0$0$0$0
Cash and Short-Term Investments$26.56M$534$3K$960$212K$501K
Accounts Receivable$1.2M$1.58M$2.37M$3.18M$376K$574K
Inventory$0$0$0$0$0$0
Other Current Assets-$1.2M-$1.62M-$2.37M-$3.18M-$183K$0
Total Current Assets$26.56M-$38K$3K$960$409K$1.08M
Long-Term Assets
Property, Plant & Equipment Net$0$0$0$0$0$0
Goodwill$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0
Long-Term Investments$773.33M$594.4M$603.68M$645.54M$553.11M$1.72B
Deferred Tax Assets$0$0$0$0$0$0
Other Long-Term Assets$0$0$2.45M$3.27M-$3.07B$0
Total Long-Term Assets$773.33M$594.4M$606.13M$648.81M-$2.51B$1.72B
Other Assets-$25.29M$1.74M$0$0$3.07B$8.75M
Total Assets$774.59M$596.1M$606.13M$648.81M$554.55M$1.73B
Liabilities
Current Liabilities
Accounts Payable$0$0$233K$12.48M$114K$0
Short-Term Debt$278K$61K$679K$212K$103K$0
Current Income Tax Payable$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0
Other Current Liabilities-$1.35M-$682K-$1.57M-$900K$7.92M$1.52M
Total Current Liabilities$0$0$0$12.48M$8.62M$1.52M
Long-Term Liabilities
Long-Term Debt$152K$61K$3K$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0
Other Long-Term Liabilities$5.88M$7.91M$5.7M$10.56M$0$0
Total Long-Term Liabilities$6.03M$7.97M$5.7M$10.56M$0$0
Other Liabilities$6.03M$7.97M$5.93M$23.04M$0$93.49M
Total Liabilities$6.03M$7.97M$5.93M$23.04M$8.62M$93.49M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0
Common Stock$942.1M$417.62M$424.3M$390.51M$339.11M$1.52B
Retained Earnings-$173.53M$170.52M$175.9M$235.27M$206.83M$117.28M
Comprehensive Income & Other$0$0$0$0$0$0
Other Stockholders' Equity$0$0$0$0$2.48B$0
Total Equity$768.57M$588.14M$600.2M$625.77M$3.02B$1.64B
Minority Interest$0$0$0$0$0$0
Total Liabilities and Equity$774.59M$596.1M$606.13M$648.81M$3.03B$1.73B
Supplementary Data
Total Debt$278K$61K$679K$212K$103K$0
Net Debt-$71K-$534-$3K-$960-$109K-$501K
Cash Flow Statement
PeriodFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Operating Activities
Net Income$23.45M$20.02M-$26.47M$59.12M$79.56M$113.23M
Depreciation & Amortization$0$0$0$0$0$0
Deferred Income Tax$0$0$0$0$0$0
Stock-Based Compensation$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$216K-$18K-$147K$5K$0$0
  Inventory$0$0$0$0$0$0
  Accounts Payable$0$0$0$0-$268K$0
  Other Working Capital$293K-$748K$472K$241K-$117K$0
Total Working Capital Change$509K-$765K$325K$246K-$385K$70.1M
Other Non-Cash Items$41.56M$12.77M$25.27M-$80.92M-$98.53M-$1.7B
Net Cash from Operating$65.52M$32.02M-$874K-$21.56M-$19.35M-$1.52B
Investing Activities
Capital Expenditures$0$0$0$0$0$0
Acquisitions$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0
Other Investing Activities$0$0$0-$36K-$970K$0
Net Cash from Investing$0$0$0-$36K-$970K$0
Financing Activities
Debt Repaid$61K-$58K-$3K---
Common Stock Issuance$0$3.02M$33.62M$50.33M$45.09M$0
Common Stock Repurchases-$29.53M$0$0$0$0$0
Dividends Paid-$35.92M-$35.1M-$32.73M-$29M-$25.65M$0
Other Financing Activities$0-$497-$20K$20K$0$1.52B
Net Cash from Financing-$65.52M-$32.02M$876K$21.34M$19.44M$1.52B
Forex Effect-$7-$28$32$0$0$19
Net Change in Cash$6K-$3K$2K-$211K$86K$9.15M
Supplementary Data
Operating Cash Flow$65.52M$32.02M-$874K-$21.56M-$19.35M-$1.52B
Capital Expenditure$0$0$0-$4$0$0
Free Cash Flow$65.52M$32.02M-$874K-$21.56M-$19.35M-$1.52B
Cash at Beginning$534$3K$960$212K$125K$100K
Cash at End$6K$534$3K$960$212K$9.25M